222 related articles for article (PubMed ID: 29794249)
1. Quality, origins and limitations of common therapeutic drug reference intervals.
McCudden CR
Diagnosis (Berl); 2018 Jun; 5(2):47-61. PubMed ID: 29794249
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
Marquet P
Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
[TBL] [Abstract][Full Text] [Related]
3. Overview of therapeutic drug monitoring.
Kang JS; Lee MH
Korean J Intern Med; 2009 Mar; 24(1):1-10. PubMed ID: 19270474
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
5. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
Prokopczyk J; Piekarczyk A; Kaminska E
Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
[TBL] [Abstract][Full Text] [Related]
6. Can pharmacokinetic variability be controlled for the patient's benefit? The place of TDM for new AEDs.
Johannessen SI
Ther Drug Monit; 2005 Dec; 27(6):710-3. PubMed ID: 16404799
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics: the therapeutic drug monitoring of the future?
Ensom MH; Chang TK; Patel P
Clin Pharmacokinet; 2001; 40(11):783-802. PubMed ID: 11735602
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M; van Gelder T; Åsberg A; Haufroid V; Hesselink DA; Langman L; Lemaitre F; Marquet P; Seger C; Shipkova M; Vinks A; Wallemacq P; Wieland E; Woillard JB; Barten MJ; Budde K; Colom H; Dieterlen MT; Elens L; Johnson-Davis KL; Kunicki PK; MacPhee I; Masuda S; Mathew BS; Millán O; Mizuno T; Moes DAR; Monchaud C; Noceti O; Pawinski T; Picard N; van Schaik R; Sommerer C; Vethe NT; de Winter B; Christians U; Bergan S
Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.
Hiemke C
Eur J Clin Pharmacol; 2008 Feb; 64(2):159-66. PubMed ID: 18196227
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic principles of immunosuppressive drugs.
Budde K; Glander P
Ann Transplant; 2008; 13(3):5-10. PubMed ID: 18806727
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
Marquet P; Rousseau A
Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
[TBL] [Abstract][Full Text] [Related]
12. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine.
Gaspar VP; Ibrahim S; Zahedi RP; Borchers CH
J Mass Spectrom; 2021 Nov; 56(11):e4788. PubMed ID: 34738286
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".
Bengtsson F
Ther Drug Monit; 2004 Apr; 26(2):145-51. PubMed ID: 15228155
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications.
Shaikh AS; Guo R
Curr Pharm Biotechnol; 2017; 18(13):1098-1105. PubMed ID: 29437004
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring of antiretrovirals for people with HIV.
Kredo T; Van der Walt JS; Siegfried N; Cohen K
Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs.
Zhang Y; Zhang R
Drug Test Anal; 2018 Jan; 10(1):81-94. PubMed ID: 28851030
[TBL] [Abstract][Full Text] [Related]
17. An audit of therapeutic drug monitoring services of anticonvulsants at a tertiary care hospital in India.
Taur SR; Kulkarni NB; Gogtay NJ; Thatte UM
Ther Drug Monit; 2013 Apr; 35(2):183-7. PubMed ID: 23407479
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring in the neurocritical care unit.
Loh GW; Mabasa VH; Ensom MH
Curr Opin Crit Care; 2010 Apr; 16(2):128-35. PubMed ID: 20168225
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for therapeutic drug monitoring of new anticonvulsants?
Perucca E
Clin Pharmacokinet; 2000 Mar; 38(3):191-204. PubMed ID: 10749516
[TBL] [Abstract][Full Text] [Related]
20. Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges.
Hiemke C
Ther Drug Monit; 2019 Apr; 41(2):174-179. PubMed ID: 30883511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
